title: Analysis of the electroencephalogram and pain characteristic in patients before and after carbamazepine treatment.
abstract: OBJECTIVE
  To determine the changes of the electroencephalogram and the changes of the quantity in percentage terms of alpha, beta, theta and delta waves in the electroencephalogram in migraine patients after a carbamazepine treatment. Analyze pain characteristics after the carbamazepine treatment of these patients and the efficiency of the carbamazepine treatment in the prevention of new attacks.
  A retrospective-prospective study has been conducted on 40 persons of approximately 42,9 years of age, with normal cranium CT finding, craniogram and fundus. They were divided in two groups: Group A--21 person who prophylactically took a daily dosage of 400 mg Carbamezepin and during acute pain attacks Naproksen; and group B--19 persons who prophylactically took daily dosage of 400 mg Carbamezepin. EEG test was done twice--before and after the medication, in order to check the concentration of different waves in the EEG in percentages. The T-test doesn't show a statistically significant difference between the alpha (p 0,719), beta 1 (p 0,865), beta 2 (p 0,710), theta (p 0,867) and delta (p 0,272) waves for the group A and for the group B alpha (p 0,996), beta 1 (p 0,920), beta 2 (p 0,826), theta (p 0,324) and delta (p 0,820) waves, on the significance level p 0,05 in the EEG at the beginning and the EEG at the end of the examination. The t-test does show a statistically significant difference between the intensity, frequency, duration and relief of pain at the beginning and at the end of the examination for both test groups.
  
  
  CONCLUSIONS
  Carbamazepin and Paracetamol do not cause changes in the EEG nor in the quantity in percentage terms of concentration of different waves in the control EEG in patients with vascular headaches. Statistically Carbamazepin and Paracetamol significantly change characteristics of pain and can be used for migraine treatment and prophylaxis.
authors.affiliation: Medical Faculty, University of Sarajevo, Bosnia and Herzegovina. miralem@gmail.com
authors.forename: Miralem
authors.initials: M
authors.lastname: Music
authors.forename: Nermina
authors.initials: N
authors.lastname: Babic
authors.forename: Almir
authors.initials: A
authors.lastname: Fajkic
authors.forename: Suad
authors.initials: S
authors.lastname: Sivic
authors.forename: Senad
authors.initials: S
authors.lastname: Huseinagic
authors.forename: Fredi
authors.initials: F
authors.lastname: Alicajic
authors.forename: Selim
authors.initials: S
authors.lastname: Toromanovic
mesh_terms: D000293:Adolescent; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D002220:Carbamazepine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control*; D010147:Pain Measurement; D055815:Young Adult
chemical_list: D018712:Analgesics, Non-Narcotic; D002220:Carbamazepine